Recent progress in the study of ApoA-containing lipoprotein particles. 1991

J C Fruchart, and G Ailhaud
SERLIA U325 Inserm, Institut Pasteur, Lille, France.

UI MeSH Term Description Entries
D008136 Longevity The normal length of time of an organism's life. Length of Life,Life Span,Lifespan,Life Spans,Lifespans
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001054 Apolipoproteins A Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE. Apo-A,ApoA

Related Publications

J C Fruchart, and G Ailhaud
March 1991, Pediatric research,
J C Fruchart, and G Ailhaud
January 1991, Progress in lipid research,
J C Fruchart, and G Ailhaud
April 1998, European journal of clinical investigation,
J C Fruchart, and G Ailhaud
September 1989, Journal of lipid research,
J C Fruchart, and G Ailhaud
May 2023, Innovation (Cambridge (Mass.)),
J C Fruchart, and G Ailhaud
January 1978, Scandinavian journal of clinical and laboratory investigation. Supplementum,
Copied contents to your clipboard!